Cooperative Research Partnerships for Biodefense (U01)

The summary for the Cooperative Research Partnerships for Biodefense (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Cooperative Research Partnerships for Biodefense (U01)
	CFDA Number:	93.856
	CFDA Description:	Microbiology and Infectious Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-07-003
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Nov 29, 2006
	Creation Date:	Nov 29, 2006
	Original Closing Date for Applications:	Jun 19, 2007
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jul 19, 2007
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$25,000,000
	Federal Grant Award Ceiling:	$300,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Small businesses Special district governments Independent school districts
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Grant Description: -Purpose. To support discovery/design and development of vaccines, therapeutics, immunotherapeutics, adjuvants and medical diagnostics for NIAID Category A, B, and C priority pathogens and toxins (http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm). -Mechanism of Support. This RFA will utilize the U01 cooperative agreement grant mechanism. -Funds Available and Anticipated Number of Awards. $25 million available to support 15-20 awards. Awards issued under this RFA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-07-003.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-07-003.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Biomedical Prevention of HIV Research Education (R25); • Partnerships for Next Generation Biodefense Diagnostics (R01); • National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7); • Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pathogens (R0...; • Non-Antibiotic Selectable Markers for Biodefense (R21); • Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Associated Inf...; • Pharmacological Approaches to Combating Antimicrobial Resistance (R01); • Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54]; • Cooperative Research Partnerships for Biodefense and Emerging Infectious Diseases (U01)